NANOBIOTIX Statement Regarding Recent Media Speculation
Nanobiotix, a late-stage clinical biotechnology company listed on Euronext and Nasdaq, has issued a statement addressing recent media speculation about a possible public takeover. The company clarified that, to its knowledge, no such takeover attempt or assessment exists and highlighted inaccuracies in the media reports, reaffirming its commitment …